EXTAVIAT Trademark

Trademark Overview

On Thursday, January 27, 2005, a trademark application was filed for EXTAVIAT with the United States Patent and Trademark Office. The USPTO has given the EXTAVIAT trademark a serial number of 79011069. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, August 18, 2011. This trademark is owned by Novartis AG. The EXTAVIAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the immune system, immuno-suppressant
extaviat

General Information

Serial Number79011069
Word MarkEXTAVIAT
Filing DateThursday, January 27, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, August 18, 2011
Registration Number3068461
Registration DateTuesday, March 14, 2006
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 20, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the immune system, immuno-suppressant

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, August 18, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, March 6, 2012DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 10, 2006FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 23, 2006FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 23, 2006FINAL DISPOSITION PROCESSED
Tuesday, October 10, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 14, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2006ASSIGNED TO EXAMINER
Tuesday, December 20, 2005PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2005NOTICE OF PUBLICATION
Thursday, October 27, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 21, 2005ASSIGNED TO LIE
Thursday, October 20, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 20, 2005CORRESPONDENCE E-MAILED
Thursday, October 20, 2005EXAMINERS AMENDMENT -WRITTEN
Thursday, October 6, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 6, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 16, 2005REFUSAL PROCESSED BY IB
Friday, August 26, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 26, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 25, 2005NON-FINAL ACTION WRITTEN
Thursday, August 25, 2005ASSIGNED TO EXAMINER
Friday, June 17, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, June 16, 2005SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

extaviat system immuno suppressant immune disorders preparations treatment diseases pharmaceutical